Market closed
Novanta/$NOVT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Novanta
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Ticker
$NOVT
Sector
Trading on
Industry
Electronic Equipment, Instruments & Components
Headquarters
Employees
2,900
Website
Novanta Metrics
BasicAdvanced
$5.5B
Market cap
92.46
P/E ratio
$1.66
EPS
1.29
Beta
-
Dividend rate
Price and volume
Market cap
$5.5B
Beta
1.29
52-week high
$187.12
52-week low
$146.86
Average daily volume
218K
Financial strength
Current ratio
2.79
Quick ratio
1.642
Long term debt to equity
66.718
Total debt to equity
67.393
Interest coverage (TTM)
3.66%
Management effectiveness
Return on assets (TTM)
5.35%
Return on equity (TTM)
8.67%
Valuation
Price to earnings (TTM)
92.455
Price to revenue (TTM)
5.975
Price to book
7.43
Price to tangible book (TTM)
-109.63
Price to free cash flow (TTM)
48.025
Growth
Revenue change (TTM)
3.86%
Earnings per share change (TTM)
-20.95%
3-year revenue growth (CAGR)
12.08%
3-year earnings per share growth (CAGR)
6.36%
What the Analysts think about Novanta
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Novanta stock.
Novanta Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Novanta Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Novanta News
AllArticlesVideos
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
Business Wire·3 days ago
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
Business Wire·4 days ago
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Novanta stock?
Novanta (NOVT) has a market cap of $5.5B as of December 22, 2024.
What is the P/E ratio for Novanta stock?
The price to earnings (P/E) ratio for Novanta (NOVT) stock is 92.46 as of December 22, 2024.
Does Novanta stock pay dividends?
No, Novanta (NOVT) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Novanta dividend payment date?
Novanta (NOVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Novanta?
Novanta (NOVT) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.